{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Andersson J"],"funding":["Anna-Lisa and Bror Björnsson Foundation","Gothenburg Medical Society","Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement","Axel Linders Foundation","University of Gothenburg","Assar Gabrielsson Foundation","Swedish Cancer Society","Alice Swenson Foundation"],"pagination":["35"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10914847"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["39(1)"],"pubmed_abstract":["Purpose
Rectal cancer and its treatment have a negative impact on health-related quality of life (HRQoL). If risk factors for sustained low HRQoL could be identified early, ideally before the start of treatment, individualised interventions could be identified and implemented to maintain or improve HRQoL. The study aimed to develop a multivariable prediction model for global HRQoL 12 months after rectal cancer treatment.Methods
Within COLOR II, a randomised, multicentre, international trial of laparoscopic and open surgery for rectal cancer, a sub-study on HRQoL included 385 patients in 12 hospitals and five countries. The HRQoL study was optional for hospitals in the COLOR II trial. EORTC QLQ-C30 and EORTC QLQ-CR38 were analysed preoperatively and at 1 and 12 months postop"],"journal":["International journal of colorectal disease"],"pubmed_title":["Developing a multivariable prediction model of global health-related quality of life in patients treated for rectal cancer: a prospective study in five countries."],"pmcid":["PMC10914847"],"funding_grant_id":["CAN 2010/593CAN 2013/497; CAN 2016/362; Pj19 0303","ALFGBG-138751; ALFGBG-4307771; ALFGBG-718221; ALFGBG-965245"],"pubmed_authors":["Gellerstedt M","Andersson J","Angenete E","Haglind E"],"additional_accession":[]},"is_claimable":false,"name":"Developing a multivariable prediction model of global health-related quality of life in patients treated for rectal cancer: a prospective study in five countries.","description":"Purpose
Rectal cancer and its treatment have a negative impact on health-related quality of life (HRQoL). If risk factors for sustained low HRQoL could be identified early, ideally before the start of treatment, individualised interventions could be identified and implemented to maintain or improve HRQoL. The study aimed to develop a multivariable prediction model for global HRQoL 12 months after rectal cancer treatment.Methods
Within COLOR II, a randomised, multicentre, international trial of laparoscopic and open surgery for rectal cancer, a sub-study on HRQoL included 385 patients in 12 hospitals and five countries. The HRQoL study was optional for hospitals in the COLOR II trial. EORTC QLQ-C30 and EORTC QLQ-CR38 were analysed preoperatively and at 1 and 12 months postop","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Mar","modification":"2026-05-29T12:06:06.005Z","creation":"2024-11-14T22:17:59.632Z"},"accession":"S-EPMC10914847","cross_references":{"pubmed":["38441657"],"doi":["10.1007/s00384-024-04605-y"]}}